The study did not comprehensively assess service readiness and availability of all diabetes tracers which includes clinical processes: capacity to provide annual HbA1C testing, LDL cholesterol testing, urine albumin creatinine ratio (UACR), screening for nephropathy, regular eye examination among others. The gene discussed is ALB; the disease is diabetes mellitus.